WO1999067286A3 - Novel staphylococcus peptides for bacterial interference - Google Patents

Novel staphylococcus peptides for bacterial interference Download PDF

Info

Publication number
WO1999067286A3
WO1999067286A3 PCT/US1999/014562 US9914562W WO9967286A3 WO 1999067286 A3 WO1999067286 A3 WO 1999067286A3 US 9914562 W US9914562 W US 9914562W WO 9967286 A3 WO9967286 A3 WO 9967286A3
Authority
WO
WIPO (PCT)
Prior art keywords
amino acid
group
peptides
cyclic
bacterial interference
Prior art date
Application number
PCT/US1999/014562
Other languages
French (fr)
Other versions
WO1999067286A9 (en
WO1999067286A2 (en
Inventor
Tom W Muir
Patricia Mayville
Richard P Novick
Guangyong Ji
Ronald Beavis
Original Assignee
Univ Rockefeller
Univ New York
Tom W Muir
Patricia Mayville
Richard P Novick
Guangyong Ji
Ronald Beavis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller, Univ New York, Tom W Muir, Patricia Mayville, Richard P Novick, Guangyong Ji, Ronald Beavis filed Critical Univ Rockefeller
Priority to CA002331888A priority Critical patent/CA2331888A1/en
Priority to AU47238/99A priority patent/AU769791B2/en
Priority to JP2000555937A priority patent/JP2002519304A/en
Priority to EP99930780A priority patent/EP1090034A2/en
Publication of WO1999067286A2 publication Critical patent/WO1999067286A2/en
Publication of WO1999067286A3 publication Critical patent/WO1999067286A3/en
Publication of WO1999067286A9 publication Critical patent/WO1999067286A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present invention provides a cyclic peptide comprising structure (I) wherein X is selected from the group consisting of an amino acid, an amino acid analog, a peptidomimetic and a non-amide isostere, Z is selected from the group consisting of a synthetic amino acid and a biosynthetic amino acid, R is selected from the group consisting of oxygen, nitrogen and carbon, n is 0 to 10 and y is 1 to 10. The present invention also provides a cyclic peptide comprising the amino acid sequence of NH2-X(n)-Z-X(y)-COOH and a cyclic bond between the Z residue and COOH other than a thioester bond, wherein X is selected from the group consisting of an amino acid, an amino acid analog, a peptidomimetic and a non-amide isostere, Z is selected from the group consisting of a synthetic amino acid and a biosynthetic amino acid, n is 0 to 10 and y is 1 to 10. Methods of preparation including a cyclization protocol, and methods of use of the cyclic peptides of the invention are also disclosed.
PCT/US1999/014562 1998-06-24 1999-06-24 Novel staphylococcus peptides for bacterial interference WO1999067286A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002331888A CA2331888A1 (en) 1998-06-24 1999-06-24 Novel staphylococcus peptides for bacterial interference
AU47238/99A AU769791B2 (en) 1998-06-24 1999-06-24 Novel Staphylococcus peptides for bacterial interference
JP2000555937A JP2002519304A (en) 1998-06-24 1999-06-24 Novel Staphylococcus Peptides for Bacterial Interference
EP99930780A EP1090034A2 (en) 1998-06-24 1999-06-24 Novel staphylococcus peptides for bacterial interference

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10343898A 1998-06-24 1998-06-24
US09/103,438 1998-06-24

Publications (3)

Publication Number Publication Date
WO1999067286A2 WO1999067286A2 (en) 1999-12-29
WO1999067286A3 true WO1999067286A3 (en) 2000-03-16
WO1999067286A9 WO1999067286A9 (en) 2000-05-04

Family

ID=22295184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/014562 WO1999067286A2 (en) 1998-06-24 1999-06-24 Novel staphylococcus peptides for bacterial interference

Country Status (5)

Country Link
EP (1) EP1090034A2 (en)
JP (1) JP2002519304A (en)
AU (1) AU769791B2 (en)
CA (1) CA2331888A1 (en)
WO (1) WO1999067286A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3047043A1 (en) * 2016-12-13 2018-06-21 Ferring B.V. Antimicrobial peptides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006998A1 (en) * 1990-10-11 1992-04-30 Boehringer Ingelheim Kg Cyclopeptides, a method of preparing them, and their use as drugs
WO1997044349A1 (en) * 1996-05-22 1997-11-27 New York University BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
WO1999026968A1 (en) * 1997-11-26 1999-06-03 The University Of Nottingham Oligopeptides and their use as antibacterial agents against staphylococcus strains

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006998A1 (en) * 1990-10-11 1992-04-30 Boehringer Ingelheim Kg Cyclopeptides, a method of preparing them, and their use as drugs
WO1997044349A1 (en) * 1996-05-22 1997-11-27 New York University BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
WO1999026968A1 (en) * 1997-11-26 1999-06-03 The University Of Nottingham Oligopeptides and their use as antibacterial agents against staphylococcus strains

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
A BALLIO ET AL.: "Novel bioactive lipodepsipeptides from Pseudomonas syringae: the pseudomycins", FEBS LETTERS, vol. 355, no. 1, 21 November 1994 (1994-11-21), AMSTERDAM NL, pages 96 - 100, XP002125309 *
C ZECHEL & H KESSLER: "Synthesis and conformational studies of enkephalin-like cyclic peptides and depsipeptides", PEPT. STRUCT. AND FUNCTION. PROC. OF THE IX AMERICAN PEPTIDE SYMPOSIUM,, 1985, Rockford, US, pages 507 - 510, XP002125308 *
M OTTO ET AL.: "Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives", FEBS LETTERS, vol. 450, no. 3, 7 May 1999 (1999-05-07), AMSTERDAM NL, pages 257 - 262, XP002125313 *
M T HAMANN ET AL.: "Kahalalides: bioactive peptides from a marine mollusk Elysia rufescens and its algal diet Bryopsis sp.", JOURNAL OF ORGANIC CHEMISTRY., vol. 61, no. 19, 1996, AMERICAN CHEMICAL SOCIETY. EASTON., US, pages 6594 - 6600, XP002125310, ISSN: 0022-3263 *
N FUKUCHI ET AL.: "Isolation and structural elucidation of syringostatins, phytotoxins produced by Pseudomonas syringae pv. syringae Lilac isolate.", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1., no. 7, 1992, CHEMICAL SOCIETY. LETCHWORTH., GB, pages 875 - 880, XP002125311, ISSN: 0300-922X *
P MAYVILLE ET AL.: "Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 96, no. 41, 16 February 1999 (1999-02-16), NATIONAL ACADEMY OF SCIENCE. WASHINGTON., US, pages 1218 - 1223, XP002125314, ISSN: 0027-8424 *
S TSUBOTANI ET AL.: "Ferrocins, new iron-containing peptide antibiotics produced by bacteria", JOURNAL OF ANTIBIOTICS, vol. 46, no. 2, February 1993 (1993-02-01), TOKYO JP, pages 287 - 293, XP002125312 *

Also Published As

Publication number Publication date
AU4723899A (en) 2000-01-10
CA2331888A1 (en) 1999-12-29
WO1999067286A9 (en) 2000-05-04
JP2002519304A (en) 2002-07-02
EP1090034A2 (en) 2001-04-11
WO1999067286A2 (en) 1999-12-29
AU769791B2 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
EP0528312A3 (en) Cyclic peptides and use thereof
IL145288A (en) Isolated cytokine zalpha11 ligand polypeptide and uses thereof
WO1998021237A3 (en) Peptide compounds useful for modulating FGF receptor activity
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
EP1013760A3 (en) Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same
DK0431350T3 (en) New polypeptide compound and process for its preparation
MX9804419A (en) Il-13 receptor polypeptide.
EP0956033A4 (en) Total synthesis of the amino hip analogue of didemnin a
PL337779A1 (en) Method of treating diarrhoeic diseases and method of eliminating specific bacterial populations from the colon
DK165120C (en) BASIC MONOCARBOXYAMIDE DERIVATIVES OF ACTAGARDIN, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE DERIVATIVES
EP1006126A3 (en) Osteogenic peptides
CA2250630A1 (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof
IE902388L (en) Vasoactive intestinal peptide analogs.
WO2000011023A3 (en) Ring modified cyclic peptide analogs
WO1999067286A3 (en) Novel staphylococcus peptides for bacterial interference
AU589289B2 (en) Novel inhibitor peptides
DE3367413D1 (en) Antibiotic compound
AU585167B2 (en) Novel substrate peptides
SG64917A1 (en) Method of peptide synthesis and new synthesis intermediates
ATE223927T1 (en) MU-OPIOID LIGANDS: AGONISTS AND ANTAGONISTS
EP0438600A4 (en) Enzymes which participate in c-terminal amidation, and production and use thereof
AU1730800A (en) A method for the preparation of n-neohexyl-alpha-aspartyl-l-phenylalanine methylester from imidazolidin-4-one intermediates
AU5162196A (en) Novel peptides and remedy for bone diseases containing the same as active ingredient
MX9709494A (en) Cyclic peptidic compounds, process for its production, compositions containing them and use of the same.
AU773969C (en) Novel tachykinin peptides, precursor peptides thereof and genes encoding the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/4-4/4, DRAWINGS, REPLACED BY NEW PAGES 1/6-6/6; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2331888

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 555937

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 47238/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999930780

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999930780

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 47238/99

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1999930780

Country of ref document: EP